Tikcro Technologies (OTCMKTS:TIKRF) Announces Earnings Results

Tikcro Technologies (OTCMKTS:TIKRF) announced its quarterly earnings results on Wednesday, June 26th. The company reported ($0.03) EPS for the quarter, reports.

OTCMKTS:TIKRF remained flat at $$0.28 on Friday. The business has a fifty day moving average of $0.26. Tikcro Technologies has a 12-month low of $0.16 and a 12-month high of $0.40.

About Tikcro Technologies

Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. It promotes a new approach for the generation of antibodies which are expected to have selectivity and blocking capabilities and, as a result, are expected to effectively modulate the immune system.

Featured Story: What are convertible shares? 

Earnings History for Tikcro Technologies (OTCMKTS:TIKRF)

Receive News & Ratings for Tikcro Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tikcro Technologies and related companies with MarketBeat.com's FREE daily email newsletter.